Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. | JCI Insight | 2023 | 36692019 | PubTator, text mining | PubMed |
| Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. | Molecules | 2023 | 36677808 | PubTator, text mining | PubMed |
| IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment. | Diagnostics (Basel) | 2023 | 36673113 | PubTator, text mining | PubMed |
| Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review. | Cells | 2023 | 36672259 | PubTator, text mining | PubMed |
| Extracellular Vesicles: New Classification and Tumor Immunosuppression. | Biology (Basel) | 2023 | 36671802 | PubTator, text mining | PubMed |
| O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation. | Mol Cell Proteomics | 2023 | 36669592 | PubTator, text mining | PubMed |
| Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism. | iScience | 2023 | 36660474 | PubTator, text mining | PubMed |
| Role of ST6GAL1 and ST6GAL2 in subversion of cellular signaling during enteroaggregative Escherichia coli infection of human intestinal epithelial cell lines. | Appl Microbiol Biotechnol | 2023 | 36646912 | PubTator, text mining | PubMed |
| Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis. | J Neuroinflammation | 2023 | 36639663 | PubTator, text mining | PubMed |
| Gemcitabine alters sialic acid binding of the glycocalyx and induces inflammatory cytokine production in cultured endothelial cells. | Med Mol Morphol | 2023 | 36622466 | PubTator, text mining | PubMed |
| The Role of B Cell and T Cell Glycosylation in Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 36614306 | PubTator, text mining | PubMed |
| A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer. | J Ovarian Res | 2023 | 36611197 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. | Cancer Cell | 2023 | 36563681 | PubTator, text mining | PubMed |
| Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma. | Immunity | 2023 | 36563676 | PubTator, text mining | PubMed |
| Circulating platelets supply ST6Gal-1 in patients with IgA nephropathy. | Postgrad Med | 2023 | 36533382 | PubTator, text mining | PubMed |
| The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees. | EBioMedicine | 2023 | 36529104 | PubTator, text mining | PubMed |
| ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface. | Oncogene | 2023 | 36528750 | PubTator, text mining | PubMed |
| A glyco-engineering approach for site-specific conjugation to Fab glycans. | MAbs | 2023 | 36447399 | PubTator, text mining | PubMed |
| Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes. | Diabetes | 2023 | 36445944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=15